Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shail Modi
Observed names:
SHAIL RAKESH MODI,
Shail Rakesh Modi
Institution:
Massachusetts College of Pharmacy and Health Sciences
Observed institution:
Massachusetts College of Pharmacy and Health Sciences
ORCID:
0000-0003-4678-4843
Observed ORCID:
0000-0003-4678-4843
OpenAlex ID:
A5052183196
Conventional vaccination methods: Inactivated and live attenuated vaccines
2024
·
Terrick Andey
, Shailvi Soni
, et al.
·
Elsevier eBooks
·
33
Modular self-emulsifying drug delivery platform to enhance cellular uptake activity in triple-negative breast cancer
2024
·
Nandini Gandhi
, Shail Modi
, et al.
·
European Journal of Pharmaceutical Sciences
·
10
Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells
2024
·
SHAIL RAKESH MODI
, TERRICK ANDEY
·
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
·
10
Abstract 551: Investigation of the antipoliferative effect of the Xylopia Aethiopicaextract in triple-negative breast cancer cells
2024
·
Shailvi Soni
, Shail Rakesh Modi
, et al.
·
Cancer Research
·
5
History of Nanoparticles
2024
·
Keshava L. Jetha
, Arya Vyas
, et al.
·
Wiley eBooks
·
4
Gene expression changes in COVID-19 patients impact pathways related to circadian rhythm, phosphatidylinositol signaling, cytokine storm, and platelet aggregation
2023
·
Shail Modi
, Nandini Gandhi
, et al.
·
Gene Reports
·
2
Abstract 4883: NFE2L3 regulates the expression of BHLHE40 in triple-negative breast cancer
2024
·
Shail Rakesh Modi
, Terrick Andey
, et al.
·
Cancer Research
·
1
The role of master regulators such as HMGA1, SOX9, FOXA1 in the development of triple‐negative breast cancer
2022
·
Shail Rakesh Modi
, Terrick Andey
, et al.
·
The FASEB Journal
·
1
BHLHE40 Is a Transcriptional Regulatory Target of NFE2L3 in Triple-Negative Breast Cancer
2026
·
Shail Modi
, Terrick Andey
, et al.
·
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Overcoming Tumor Resistance to Gefitinib and Erlotinib in Non-Small Cell Lung Cancer Using Piperlongumine
2024
·
Terrick A. Andey
, Shail Modi
·
American Journal of Pharmaceutical Education
Show more works
View as search
Works count:
11
Citation count:
66
H-index:
4
I10-index:
3
Year
Topic
Type